Company news

Noxopharm Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Idronoxil data provides hope to treat secondary brain cancer

June 18, 2017

NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment

June 4, 2017

St Vincents Cancer Study to Commence-NOX66 and Radiotherapy

May 28, 2017

NOX makes strategic commitment to treatment of rare cancers

May 23, 2017

Market Guidance for Next Six Months

May 1, 2017

NOX Files Patent Application on Smart Idronoxil

April 9, 2017

NOX and Monash Uni Collaboration Receives Federal Grant

March 26, 2017

Noxopharm and UNSW combine on stroke project

March 15, 2017

NOX researching rare Abscopal Response

March 3, 2017

Brain Cancer Study Commences

January 31, 2017

First NOX66 Clinical Trial to Commence

January 30, 2017

Breakthrough in Delivering Idronoxil into Brain

November 22, 2016

Initial Clinic Study Announced and Approved

October 25, 2016

Amendment to Preliminary Final Report

September 30, 2016

Preliminary Final Report

August 31, 2016

Noxopharm to Initiate Radiotherapy Clinical Studies

August 22, 2016

Noxopharm Provides Update on Inaugural Clinical Study

August 9, 2016

ASX Market Release - Admission to Official List

August 8, 2016

← Newer news releases

Decks

The 5 newest of 53 decks. Every deck is listed under its year.